次新異動 | 匯森家居漲超8%,上市四日累漲30%
uSMART盈立智投1月4日消息,週一港股早盤,匯森家居上演四連陽,截至10:19分,匯森家居漲8.37%,報2.33港元,上市四個交易日,累計漲超30%。
匯森家居主要從事以原設計製造方式生產及銷售板式傢俱的業務,往績記錄期內,板式傢俱的收益佔比保持在90%之上。集團所生產的傢俱產品主要以批發形式直接或透過傢俱貿易商出售到海外市場。
以2019年度出口額計,匯森家居是中國最大的板式傢俱出口商,惟中國板式傢俱出口市場零散,集團所佔市場份額不足4%。
《新股配售 | 匯森家居一手中籤率20%,逾16萬人申購,公開認購53.4倍,國配2.25倍,有綠鞋》
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.